electra life sciences ltd
electra life sciences ltd Company Information
Company Number
12564125
Next Accounts
Jan 2026
Directors
Shareholders
alessio lanna
guido moretti
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
607 sloane avenue, london, SW3 3EL
Website
-electra life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of ELECTRA LIFE SCIENCES LTD at £309.9k based on a Turnover of £268.4k and 1.15x industry multiple (adjusted for size and gross margin).
electra life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of ELECTRA LIFE SCIENCES LTD at £0 based on an EBITDA of £-1.9k and a 4.32x industry multiple (adjusted for size and gross margin).
electra life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of ELECTRA LIFE SCIENCES LTD at £0 based on Net Assets of £-3.5k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Electra Life Sciences Ltd Overview
Electra Life Sciences Ltd is a live company located in london, SW3 3EL with a Companies House number of 12564125. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2020, it's largest shareholder is alessio lanna with a 45.9% stake. Electra Life Sciences Ltd is a young, micro sized company, Pomanda has estimated its turnover at £268.4k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Electra Life Sciences Ltd Health Check
Pomanda's financial health check has awarded Electra Life Sciences Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £268.4k, make it smaller than the average company (£3.7m)
- Electra Life Sciences Ltd
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 39%, show it is growing at a faster rate (13.5%)
- Electra Life Sciences Ltd
13.5% - Industry AVG
Production
with a gross margin of 31.1%, this company has a higher cost of product (57%)
- Electra Life Sciences Ltd
57% - Industry AVG
Profitability
an operating margin of -0.7% make it more profitable than the average company (-10.8%)
- Electra Life Sciences Ltd
-10.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (47)
- Electra Life Sciences Ltd
47 - Industry AVG
Pay Structure
on an average salary of £82.6k, the company has an equivalent pay structure (£82.6k)
- Electra Life Sciences Ltd
£82.6k - Industry AVG
Efficiency
resulting in sales per employee of £134.2k, this is equally as efficient (£129.5k)
- Electra Life Sciences Ltd
£129.5k - Industry AVG
Debtor Days
it gets paid by customers after 131 days, this is later than average (54 days)
- Electra Life Sciences Ltd
54 days - Industry AVG
Creditor Days
its suppliers are paid after 197 days, this is slower than average (57 days)
- Electra Life Sciences Ltd
57 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Electra Life Sciences Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Electra Life Sciences Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 103.7%, this is a higher level of debt than the average (50.8%)
103.7% - Electra Life Sciences Ltd
50.8% - Industry AVG
ELECTRA LIFE SCIENCES LTD financials
Electra Life Sciences Ltd's latest turnover from April 2024 is estimated at £268.4 thousand and the company has net assets of -£3.5 thousand. According to their latest financial statements, we estimate that Electra Life Sciences Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Turnover | 99,400 | 100,000 | ||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | 99,400 | 100,000 | ||
| Admin Expenses | 198 | 600 | ||
| Operating Profit | -810 | 99,202 | 99,400 | |
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | -810 | 99,202 | 99,400 | |
| Tax | ||||
| Profit After Tax | -810 | 99,202 | 99,400 | |
| Dividends Paid | ||||
| Retained Profit | -810 | 99,202 | 99,400 | |
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* | -810 | 99,202 | 99,400 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | ||||
| Stock & work in progress | ||||
| Trade Debtors | 96,472 | 98,392 | ||
| Group Debtors | ||||
| Misc Debtors | ||||
| Cash | 99,400 | 100,000 | ||
| misc current assets | ||||
| total current assets | 96,472 | 98,392 | 99,400 | 100,000 |
| total assets | 96,472 | 98,392 | 99,400 | 100,000 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 99,999 | |||
| Group/Directors Accounts | ||||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 198 | 600 | ||
| total current liabilities | 99,999 | 198 | 600 | |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | 99,999 | |||
| provisions | ||||
| total long term liabilities | 99,999 | |||
| total liabilities | 99,999 | 99,999 | 198 | 600 |
| net assets | -3,527 | -1,607 | 99,202 | 99,400 |
| total shareholders funds | -3,527 | -1,607 | 99,202 | 99,400 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | -810 | 99,202 | 99,400 | |
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | -1,920 | 98,392 | ||
| Creditors | 99,999 | |||
| Accruals and Deferred Income | -198 | -402 | 600 | |
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | -99,400 | 98,800 | 100,000 | |
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | ||||
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | -99,999 | 99,999 | ||
| share issue | ||||
| interest | ||||
| cash flow from financing | -99,400 | |||
| cash and cash equivalents | ||||
| cash | -99,400 | -600 | 100,000 | |
| overdraft | ||||
| change in cash | -99,400 | -600 | 100,000 |
electra life sciences ltd Credit Report and Business Information
Electra Life Sciences Ltd Competitor Analysis
Perform a competitor analysis for electra life sciences ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SW3 area or any other competitors across 12 key performance metrics.
electra life sciences ltd Ownership
ELECTRA LIFE SCIENCES LTD group structure
Electra Life Sciences Ltd has no subsidiary companies.
Ultimate parent company
ELECTRA LIFE SCIENCES LTD
12564125
electra life sciences ltd directors
Electra Life Sciences Ltd currently has 1 director, Dr Alessio Lanna serving since Apr 2020.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Alessio Lanna | England | 38 years | Apr 2020 | - | Director |
P&L
April 2024turnover
268.4k
0%
operating profit
-1.9k
0%
gross margin
31.2%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
-3.5k
+1.19%
total assets
96.5k
-0.02%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
electra life sciences ltd company details
company number
12564125
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
April 2020
age
5
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
607 sloane avenue, london, SW3 3EL
Bank
-
Legal Advisor
-
electra life sciences ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to electra life sciences ltd.
electra life sciences ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELECTRA LIFE SCIENCES LTD. This can take several minutes, an email will notify you when this has completed.
electra life sciences ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
